Intravitreal ranibizumab for retinopathy of prematurity: The ocular and systemic safety profile query

Bibliographic Details
Main Authors:	Khulood Al Kalbani, Anuradha Ganesh
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2023-01-01
Series:	Oman Journal of Ophthalmology
Online Access:	http://www.ojoonline.org/article.asp?issn=0974-620X;year=2023;volume=16;issue=3;spage=397;epage=398;aulast=Al

Similar Items

Intravitreal ranibizumab injections in patients with retinopathy of prematurity (ROP)
by: Zuluaga Gómez, Liliana María, et al.
Published: (2018-01-01)

Intravitreal ranibizumab for postlaser anterior segment ischemia in retinopathy of prematurity
by: Vasumathy Vedantham
Published: (2022-01-01)

Efficacy evaluation of intravitreal ranibizumab therapy for three types of retinopathy of prematurity
by: Qiong Zou, et al.
Published: (2022-05-01)

Asymmetric Outcomes of Type 1 Retinopathy of Prematurity after Bilateral Intravitreal Ranibizumab Treatment
by: Qiujing Huang, et al.
Published: (2017-01-01)

Combination of Intravitreal Injection of Ranibizumab and Photocoagulation for the Treatment of Aggressive Posterior Retinopathy of Prematurity with Vitreous Hemorrhage
by: Yu Xu, et al.
Published: (2016-01-01)

Ocular and Systemic Results of Intravitreal Bevacizumab Injection in Retinopathy of Prematurity Treatment
by: Sadik Gorkem Cevik, et al.
Published: (2020-08-01)

Recurrence risk factors of intravitreal ranibizumab monotherapy in retinopathy of prematurity: a retrospective study at one center
by: Feng-Yue Wu, et al.
Published: (2023-01-01)

Fluorescein Angiographic Findings of Peripheral Retinal Vasculature after Intravitreal Conbercept versus Ranibizumab for Retinopathy of Prematurity
by: Enzhong Jin, et al.
Published: (2019-01-01)

Serum Vascular Endothelial Growth Factor Levels before and after Intravitreous Ranibizumab Injection for Retinopathy of Prematurity
by: Xuting Chen, et al.
Published: (2019-01-01)

Treatment of Radiation Retinopathy with Intravitreal Injection of Ranibizumab (Lucentis®)
by: Horowitz SA, et al.
Published: (2020-02-01)

Comparison of intravitreal ranibizumab and diod laser photocoagulation treatment for retinopathy of prematurity; effects on axial lenght and refractive status
by: Yusuf Koçluk, et al.
Published: (2019-03-01)

Evaluation of retinal vascularization in retinopathy of prematurity regressed after intravitreal ranibizumab monotherapy or without treatment based on fluorescein angiography
by: Lei Wu, et al.
Published: (2023-11-01)

The efficacy and ocular safety following aflibercept, conbercept, ranibizumab, bevacizumab, and laser for retinopathy of prematurity: a systematic review and meta-analysis
by: Jing Chen, et al.
Published: (2023-10-01)

Effect of intravitreal ranibizumab on fibrovascular membranes in patients with proliferative diabetic retinopathy
by: Ze-Yu Liang, et al.
Published: (2022-10-01)

Effect of ranibizumab on retinopathy of prematurity: A meta-analysis
by: Zhibin Wang, et al.
Published: (2022-08-01)

Refractive profile of children treated with intravitreal bevacizumab for retinopathy of prematurity
by: Neelam Pawar, et al.
Published: (2023-01-01)

Long-term peripheral retinal vascular behavior in retinopathy of prematurity patients treated with ranibizumab intravitreal injection as monotherapy using fluorescein angiography
by: Raghad Al Rasheed, et al.
Published: (2022-08-01)

Efficacy and Safety of Intravitreal Conbercept, Ranibizumab, and Triamcinolone on 23-Gauge Vitrectomy for Patients with Proliferative Diabetic Retinopathy
by: Jinglin Cui, et al.
Published: (2018-01-01)

Efficacy of a biosimilar ranibizumab monotherapy for the treatment of retinopathy of prematurity
by: Vipul Prajapati, et al.
Published: (2023-01-01)

Comparison of Single-Treatment Efficacy of Bevacizumab and Ranibizumab for Retinopathy of Prematurity
by: Fumio Takano, et al.
Published: (2024-07-01)

Ranibizumab for the treatment of retinopathy of prematurity: systematic review and meta-analysis
by: Niza Alva, et al.
Published: (2023-08-01)

Post-Ranibizumab injection endophthalmitis in aggressive posterior retinopathy of prematurity
by: Parijat Chandra, et al.
Published: (2019-01-01)

Reactivation of retinopathy of prematurity after intravitreal bevacizumab monotherapy in aggressive posterior retinopathy of prematurity
by: Ritesh Verma, et al.
Published: (2023-01-01)

Comparison of intravitreal injection of ranibizumab versus bevacizumab for treatment of type 1 and aggressive retinopathy of prematurity in rural Egypt. A randomized clinical trial
by: Ghada Mahmoud Tawfik, et al.
Published: (2022-10-01)

Intravitreal Ranibizumab for Stage IV Proliferative Sickle Cell Retinopathy: A First Case Report
by: Panagiotis G. Mitropoulos, et al.
Published: (2014-01-01)

Safety and efficacy profile of intravitreal ranibizumab vs dexamethasone in treatment of naïve diabetic macular edema
by: Santosh K Mahapatra, et al.
Published: (2024-01-01)

Refractive and Biometric Outcomes in Patients with Retinopathy of Prematurity Treated with Intravitreal Injection of Ranibizumab as Compared with Bevacizumab: A Clinical Study of Correction at Three Years of Age
by: Yen-Chih Chen, et al.
Published: (2018-01-01)

Effect of intravitreal bevacizumab for retinopathy of prematurity on weight gain.
by: Shumpei Obata, et al.
Published: (2021-01-01)

Endophthalmitis in Retinopathy of Prematurity after Intravitreal Aflibercept Injection
by: Elcin Suren, et al.
Published: (2020-01-01)

Intravitreal aflibercept injection in Indian eyes with retinopathy of prematurity
by: Vasumathy Vedantham
Published: (2019-01-01)

Multiple Intravitreal Ranibizumab Injections for Persistant Choroidal Neovascularization Associated with Presumed Ocular Histoplasmosis Syndrome
by: Turgut Yılmaz, et al.
Published: (2017-03-01)

Ocular morbidities of premature children with mild or no retinopathy of prematurity
by: Murat Küçükevcilioğlu, et al.
Published: (2015-04-01)

Successful Resolution of Preretinal Haemorrhage with Intravitreal Ranibizumab
by: Baharuddin Noorlaila, et al.
Published: (2016-01-01)

Intraocular pressure effect of intravitreal conbercept injection for retinopathy of prematurity
by: Caifeng Gao, et al.
Published: (2023-05-01)

Comparison of the Efficacy and Safety of Intravitreal Conbercept with Intravitreal Ranibizumab for Treatment of Diabetic Macular Edema: A Meta-Analysis
by: Xiaolei Sun, et al.
Published: (2020-01-01)

Comparison of ranibizumab and conbercept treatment in type 1 prethreshold retinopathy of prematurity in zone II
by: Xiu-Mei Yang, et al.
Published: (2024-08-01)

Prophylaxis of Macular Edema with Intravitreal Ranibizumab in Patients with Diabetic Retinopathy after Cataract Surgery: A Pilot Study
by: Patricia Udaondo, et al.
Published: (2011-01-01)

Intravitreal Ranibizumab for Subfoveal Choroidal Neovascularization from Age-Related Macular Degeneration with Combined Severe Diabetic Retinopathy
by: So Young Han, et al.
Published: (2015-02-01)

Comparison of efficacy and safety of intravitreal ranibizumab and conbercept before vitrectomy in Chinese proliferative diabetic retinopathy patients: a prospective randomized controlled trial
by: Siying Li, et al.
Published: (2022-12-01)

Assessment of effect of intravitreal ranibizumab injection on the ocular blood flow in patients with neovascular age-related macular degeneration
by: V. V. Neroev, et al.
Published: (2014-07-01)